However, these mainstream therapies face critical limitations including the rapid emergence of drug resistance, FKS1/FKS2 gene mutations reducing -1,3-glucan synthase affinity, Targeted enzyme (Erg11p) modification, overexpression of efflux pumps (CDR1, MDR1), and upregulation of the ergosterol pathway mediate azole resistance (Pristov and Ghannoum, 2019)
Need the standalone version
It is unclear how long it may take until there are any health benefits of IGF-1 LR3 when used in vivo
By the age of 50, approximately 50% of men will experience some degree of hair loss
Eryptosis may contribute to accelerated RBC clearance in a number of systemic diseases like hemolytic uremic syndrome and in sepsis (Lang et al., 2008)
The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system